ATP III update targets high-risk patients, statins market to benefit? Comment 30 January 2013 Pages: 2 - 2
COX-2s confer QOL benefit in clinical practice in Latin America Meeting report 30 January 2013 Pages: 3 - 4
New guidelines for MTCT of HIV infections published by WHO Media release 30 January 2013 Pages: 4 - 4
Oseltamivir warranted for influenza among paediatric individuals? Clinical study 30 January 2013 Pages: 6 - 6
Predictors of the costs of psychotic disorders in Australia Clinical study 30 January 2013 Pages: 6 - 6
Hep A vaccination programme not worthwhile in The Netherlands Clinical study 30 January 2013 Pages: 9 - 9
Hospitalisations, productivity losses drive CAP costs in NZ Clinical study 30 January 2013 Pages: 9 - 9
Indirect costs account for majority of migraine cost burden in Spain Clinical study 30 January 2013 Pages: 9 - 9
ADRs increase hospital readmission rate, costs in Germany Clinical study 30 January 2013 Pages: 10 - 10
Current treatment for mental disorders suboptimal in Australia Clinical study 30 January 2013 Pages: 10 - 10
Bill & Melinda Gates foundation funds HIV/AIDS, TB initiatives News item 30 January 2013 Pages: 11 - 11
Overspending payback decree could spell collapse for Italian pharma News item 30 January 2013 Pages: 11 - 11